Mycoses

Aims & Scope

The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi.

Medical mycology as part of medical microbiology is advancing rapidly.

Effective therapeutic strategies are already available in chemotherapy and are being further developed.

Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research.

Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress.

The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.1
2024	4.10

SJR (SCImago Journal Rank)

Year	Value
2024	0.927

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	91

Journal Rank

Year	Value
2024	5466

Journal Citation Indicator

Year	Value
2024	1706

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Epidemiological trends in skin mycoses worldwide

  Citation: 945

  Authors: Blanka, Viktor A., Markus

• Molecular diagnostics of clinical strains of filamentous Basidiomycetes

  Citation: 474

  Authors: G. S., A. H. G. Gerrits

• COVID‐19 associated pulmonary aspergillosis

  Citation: 461

  Authors: Philipp, Oliver A., Bernd W., Fabian, Dennis A., Frieder, Michael, Norma, Florian, Thorsten, Jan, Matthias, Boris, Alexander

• Hydrolytic enzymes as virulence factors of <i>Candida albicans</i>

  Citation: 420

  Authors: Martin, Claudia, Hans C., Bernhard

• Antifungal drug resistance among <i>Candida</i> species: mechanisms and clinical impact

  Citation: 335

  Authors: Maurizio, Brunella, Cornelia

• The Clinical Pharmacokinetics of Itraconazole: An Overview

  Citation: 305

  Authors: J., A., V., P., W., K., R., J., G.

• The changing face of epidemiology of invasive fungal disease in Europe

  Citation: 304

  Authors: Cornelia

• High terbinafine resistance in <i>Trichophyton interdigitale</i> isolates in Delhi, India harbouring mutations in the squalene epoxidase gene

  Citation: 293

  Authors: Ashutosh, Aradhana, Ananta, Pradeep Kumar, Meenakshi, Ferry, Jacques F., Anuradha

• An outbreak due to <i>Candida auris</i> with prolonged colonisation and candidaemia in a tertiary care European hospital

  Citation: 293

  Authors: Alba, Ana M., María, Ana I., Héctor, Eva, Miguel, Paula, José L., Ferry, Jacques F., Juan, Javier

• <i>Aspergillus flavus</i>: an emerging non‐<i>fumigatus Aspergillus</i> species of significance

  Citation: 216

  Authors: Suganthini, Elias K., Pranatharthi H.

---